The production of fine chemicals by biotransformations.
暂无分享,去创建一个
[1] Andreas Schmid,et al. Pilot-scale production of (S)-styrene oxide from styrene by recombinant Escherichia coli synthesizing styrene monooxygenase. , 2002, Biotechnology and bioengineering.
[2] L. W. Powell,et al. A Practical and Robust Process to Produce SB-214857, Lotrafiban, ((2S)-7-(4,4‘-Bipiperidinylcarbonyl)-2,3,4,5-tetrahydro-4-methyl-3-oxo-1H-1, 4-Benzodiazepine-2-acetic Acid) Utilising an Enzymic Resolution as the Final Step , 2002 .
[3] V. Nagarajan,et al. Biocatalysis: applications and potentials for the chemical industry. , 2002, Trends in biotechnology.
[4] R. Heeren,et al. Bioconversion of N-Butylglucamine to 6-Deoxy-6-butylamino Sorbose by Gluconobacter oxydans , 2002 .
[5] P. Mullins,et al. Kinetic Resolution of β-Amino Esters by Acylation Using Immobilized Penicillin Amidohydrolase , 2002 .
[6] Junhua Tao and,et al. Development of a Continuous Enzymatic Process for the Preparation of (R)-3-(4-Fluorophenyl)-2-hydroxy Propionic Acid , 2002 .
[7] J. W. Wong,et al. Biocatalytic Oxidation of 2-Methylquinoxaline to 2-Quinoxalinecarboxylic Acid , 2002 .
[8] M. Manzoni,et al. Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs , 2002, Applied Microbiology and Biotechnology.
[9] Ramesh N. Patel,et al. Biocatalytic synthesis of intermediates for the synthesis of chiral drug substances. , 2001, Current opinion in biotechnology.
[10] Hans-Ulrich Blaser,et al. Enantioselective catalysis in fine chemicals production. , 2001, Chemical communications.
[11] A. Bommarius,et al. The membrane reactor in the fine chemicals industry , 2001 .
[12] Edgar Voss,et al. Enzyme-catalyzed processes in pharmaceutical industry , 2001 .
[13] J J Heijnen,et al. Influence of the ethanol and glucose supply rate on the rate and enantioselectivity of 3-oxo ester reduction by baker's yeast. , 2001, Biotechnology and bioengineering.
[14] Ramesh N. Patel,et al. Enzymatic synthesis of chiral intermediates for Omapatrilat, an antihypertensive drug. , 2001, Biomolecular engineering.
[15] H. Schoemaker,et al. Aminoamidase-Catalyzed Preparation and Further Transformations of Enantiopure α-Hydrogen- and α,α-Disubstituted α-Amino Acids , 2001 .
[16] A. Kiener,et al. Industrial biocatalysis today and tomorrow , 2001, Nature.
[17] R. Hanson,et al. Regioselective enzymatic aminoacylation of lobucavir to give an intermediate for lobucavir prodrug. , 2000, Bioorganic & medicinal chemistry.
[18] R. Jain,et al. Enzymatic kinetic resolution of piperidine atropisomers: synthesis of a key intermediate of the farnesyl protein transferase inhibitor, SCH66336. , 2000, The Journal of organic chemistry.
[19] S. Hashimoto,et al. Whole microbial cell processes for manufacturing amino acids, vitamins or ribonucleotides. , 1999, Current opinion in biotechnology.
[20] B Schulze,et al. Biocatalysis for industrial production of fine chemicals. , 1999, Current opinion in biotechnology.
[21] G J Lye,et al. Application of in situ product-removal techniques to biocatalytic processes. , 1999, Trends in biotechnology.
[22] R. Sheldon,et al. Dynamic kinetic resolution of phenylglycine esters via lipase-catalysed ammonolysis , 1999 .
[23] Amihay Freeman,et al. Effect of processing parameters on the feasibility and operational stability of immobilized viable microbial cells , 1998 .
[24] Andreas S. Bommarius,et al. Biocatalysis to amino acid-based chiral pharmaceuticals—examples and perspectives , 1998 .
[25] William R. Strohl,et al. Biotechnology of antibiotics , 1997 .
[26] M. Zmijewski,et al. Large-scale stereoselective enzymatic ketone reduction with in situ product removal via polymeric adsorbent resins , 1997 .
[27] M. Dawson,et al. Efficient procedures for the large-scale preparation of (1S,2S)-trans-2-methoxycyclohexanol, a key chiral intermediate in the synthesis of tricyclic β-lactam antibiotics , 1996 .
[28] W. Haiyan,et al. Highly stereoselective access to novel 2,2,4-substituted tetrahydrofurans by halocyclization: Practical chemoenzymatic synthesis of Sch 51048, a broad-spectrum orally active antifungal agent , 1995 .
[29] Li Ws,et al. Enzymic preparation of (3R‐cis)‐3‐(acetyloxy)‐4‐phenyl‐2‐azetidinone: a taxol side‐chain synthon , 1994, Biotechnology and applied biochemistry.
[30] W. Wostl,et al. Large scale preparation of chiral building blocks for the P3 site of renin inhibitors. , 1994, Bioorganic & medicinal chemistry.
[31] I. Purvis,et al. Enzymatic production of optically pure (2'R-cis)-2'-deoxy-3'-thiacytidine (3TC, lamivudine): a potent anti-HIV agent. , 1993, Enzyme and microbial technology.
[32] C. Wandrey,et al. Operational stability of enzymes. Acylase-catalyzed resolution of N-acetyl amino acids to enantiomerically pure L-amino acids. , 1992, Annals of the New York Academy of Sciences.
[33] C. Wandrey,et al. Operational Stability of Enzymes , 1992 .
[34] Ramesh N. Patel,et al. Enantioselective enzymatic acetylation of racemic [4-[4α,6β (E)]]-6-[4,4-bis(4-fluorophenyl)-3-(1-methyl-1H-tetrazol-5-yl)-1,3-butadienyl]-tetrahydro-4-hydroxy-2H-pyran-2-one , 1992, Applied Microbiology and Biotechnology.
[35] D. Gygax,et al. Optimization of a process for the production of (R)-2-hydroxy-4-phenylbutyric acid--an intermediate for inhibitors of angiotensin converting enzyme. , 1992, Journal of biotechnology.
[36] B. Buckland,et al. Development of a large‐scale continuous substrate feed process for the biotransformation of simvastatin by Nocardia s.p. , 1991, Biotechnology and bioengineering.
[37] Lynda B. M. Ellis,et al. The University of Minnesota Biocatalysis/Biodegradation Database: emphasizing enzymes , 2001, Nucleic Acids Res..
[38] A. Bruggink. Synthesis of β-Lactam Antibiotics , 2001 .
[39] Gisela Hieber,et al. Introducing ChiPros: Biocatalytic production of chiral intermediates on a commercial scale , 2001 .
[40] E. Vroom,et al. Innovations in cephalosporin and penicillin production : Painting the antibiotics industry green , 2000 .
[41] D. Cowan. Microbial genomes--the untapped resource. , 2000, Trends in biotechnology.
[42] F. Gualtieri. New trends synthetic medicinal chemistry , 2000 .
[43] Michael C. Flickinger,et al. encyclopedia of bioprocess technology , 1999 .
[44] J. Ogawa,et al. Microbial enzymes: new industrial applications from traditional screening methods. , 1999, Trends in Biotechnology.
[45] M. Dawson,et al. CHEMOENZYMATIC PRODUCTION OF THE ANTIVIRAL AGENT EPIVIR , 1997 .
[46] Kurt Faber,et al. Biotransformations in Organic Chemistry , 1992 .